Bone Metastasis Model
Bone Metastasis Model - Related Videos
08:49
Models of Bone Metastasis
0 Views •
Cited by 115 •
2012
Animal models are frequently utilized to study cancer metastasis to bone. In this protocol we will describe two common methods of tumor inoculation for bone metastasis studies and briefly describe some of the analyses utilized to monitor and quantify these models.
07:00
Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
0 Views •
Cited by 43 •
2016
This manuscript provides the detailed procedure of intra-iliac artery (IIA) injection, a technique to deliver cancer cells specifically to hind limb tissues including bones to establish experimental bone metastases. Although initially established with breast tumor models, this protocol can be easily extended to other cancer types.
12:23
Multi-modal Imaging of Angiogenesis in a Nude Rat Model of Breast Cancer Bone Metastasis Using Magnetic Resonance Imaging, Volumetric Computed Tomography and Ultrasound
0 Views •
Cited by 16 •
2012
In the pathogenesis of bone metastasis, angiogenesis is a crucial process and therefore represents a target for imaging and therapy. Here, we present a rat model of site-specific breast cancer bone metastasis and describe strategies to non-invasively image angiogenesis in vivo using magnetic resonance imaging, volumetric computed tomography and ultrasound.
06:53
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
0 Views •
Cited by 14 •
2020
Bone metastasis models do not develop metastasis uniformly or with a 100% incidence. Direct intra-osseous tumor cell injection can result in embolization of the lung. We present our technique modeling primary bone tumors and bone metastasis using solid tumor graft implantation into bone, leading to reproducible engraftment and growth.
12:03
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
0 Views •
Cited by 6 •
2016
This manuscript describes the development of an animal model that allows for the direct testing of the effects of tumor hypoxia on metastasis and the deciphering the mechanisms of its action. Although the experiments described here focus on Ewing sarcoma, a similar approach can be applied to other tumor types.
FAQs
The lesion pattern reflects how tumor-derived signals reshape bone remodeling. In osteolytic disease, altered remodeling is associated with bone loss, whereas osteoblastic disease is associated with abnormal bone formation. The surrounding mineralized matrix can also release growth factors, creating feedback that supports further tumor growth and skeletal change. Models use these patterns to examine disease progression.
Bone-resident cells are active participants rather than passive surroundings. Osteoblasts and osteoclasts interact with tumor cells, while the mineralized matrix provides a structurally and biologically relevant context. By reproducing these interactions, a model can reveal how cancer cells influence bone remodeling and how bone-associated signals may support colonization or expansion. This connects cellular behavior with skeletal complications.
Each format provides a different experimental setting. Cultured bone environments can examine local interactions among tumor cells, bone cells, and matrix, while organoids and animal systems offer other levels of experimental organization and biological context. Animal systems can represent dissemination, bone homing, and growth in a living organism. The choice should match the mechanism or outcome under investigation.
A useful model should distinguish dissemination, bone homing, and growth within bone rather than treating metastasis as a single event. Tracking these stages helps investigators determine whether a finding concerns spread, arrival at skeletal tissue, or subsequent colonization. This distinction improves interpretation of changes in bone remodeling, osteolytic or osteoblastic lesions, and tumor development within the skeletal environment.
Bone metastasis models support more than mechanism studies. They can evaluate imaging approaches and biomarkers, allowing researchers to examine how disease-related changes are detected or characterized. The same systems help test therapies directed at tumor growth, skeletal damage, or cancer-related pain. Their value lies in connecting biological processes with clinically relevant measurements and treatment goals.
In medicine, these models are especially relevant because bone involvement can combine tumor progression with skeletal damage and cancer-related pain. A system that includes tumor cells, osteoblasts, osteoclasts, and mineralized matrix can help assess these linked outcomes together. This broader view supports evaluation of interventions aimed not only at cancer cells but also at the consequences of disease in bone.